Zobrazeno 1 - 10 of 28 pro vyhledávání: '"Göran Långström"'
2
Performance of the Population Bioequivalence (PBE) Statistical Test with Impactor Sized Mass Data
Autor: Beth Morgan, David Christopher, Helen Strickland, Svetlana Lyapustina, Christopher Wiggenhorn, Stephanie T. Chen, Elise Burmeister Getz, Hayden Beresford, Göran Långström
Publikováno v: AAPS PharmSciTech. 20(7)
This article extends previous work studying performance characteristics of the population bioequivalence (PBE) statistical test recommended by the US Food and Drug Administration (FDA) for orally inhaled and nasal drug products. Based on analysis of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1add8c15dc043cf2fd5c90c6d77aba27
https://pubmed.ncbi.nlm.nih.gov/31444601
Zobrazit plný text záznamu
3
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
Autor: Jan Gunnar Hatlebakk, M. Jahreskog, Roberto Fiocca, Stephen Attwood, C. Ell, Göran Långström, Stefan Eklund, J. P. Galmiche, B. Hasselgren, Tore Lind, Lars Lundell
Publikováno v: Alimentary Pharmacology & Therapeutics. 41:1162-1174
SummaryBackground Control of chronic gastro-oesophageal reflux disease may be achieved either by anti-reflux surgery (ARS) or by long-term medical therapy with proton pump inhibitors (PPIs). The primary efficacy results of the SOPRAN study, comparing
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aeb5b768987198e41bfe353212171c7
https://doi.org/10.1111/apt.13194
Zobrazit plný text záznamu
7
Phase I, Multicenter, Randomized, Open-Label Study Evaluating the Pharmacokinetics and Safety Profile of Repeated Once-Daily Doses of Intravenous Esomeprazole in Children 0 to 17 Years of Age
Autor: Marie Sandström, Kurt Brown, Per Lundborg, Vasundhara Tolia, Janice E. Sullivan, Geoffrey P. Davidson, Göran Långström
Publikováno v: Clinical Therapeutics. 34:1828-1838
Background Several oral proton pump inhibitors (PPIs) are currently approved for use in pediatric patients in North America and Europe. However, when use of oral therapy is not possible or appropriate, intravenous formulations of PPIs may be helpful.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54478c1c36914f1d2e052735f16d946e
https://doi.org/10.1016/j.clinthera.2012.06.028
Zobrazit plný text záznamu
8
Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects
Autor: Tommy B. Andersson, Mohammed Hassan-Alin, Göran Långström, Jorgen Naesdal, Catharina Nilsson-Pieschl
Publikováno v: Clinical Drug Investigation. 25:731-740
Background: We investigated the potential interactions between esomeprazole and a non-selective nonsteroidal anti-inflammatory drug (NSAID; naproxen) or a cyclo-oxygenase (COX)-2-selective NSAID (rofecoxib) in healthy subjects. Methods: Two studies o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff71037f52edb6038d941780828c6c8
https://doi.org/10.2165/00044011-200525110-00006
Zobrazit plný text záznamu
9
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users
Autor: Göran Långström, I Wilson, Neville D. Yeomans, Christopher J. Hawkey, Jorgen Naesdal, A J Swannell
Publikováno v: Gut. 51:344-350
Background and aims: Factors predisposing to endoscopic ulcer formation or healing with non-steroidal anti-inflammatory drugs (NSAIDs) have not been well defined. Methods: We used multivariate analysis of data from three large similar trials to ident
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bfbbd9083a8b8e300c351f10f70cc2a
https://doi.org/10.1136/gut.51.3.344
Zobrazit plný text záznamu
10
Management of gastroduodenal ulcers and gastrointestinal symptoms associated with nonsteroidal anti-inflammatory drug therapy: A summary of four comparative trials with omeprazole, ranitidine, misoprostol, and placebo
Autor: Anders Walan, P Wahlqvist, Ingela Wiklund, Jorgen Naesdal, I Wilson, Göran Långström
Publikováno v: Current Therapeutic Research. 62:835-850
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in the treatment of systemic diseases such as rheumatoid arthritis but are associated with a range of adverse gastrointestinal (GI) side effects, including dyspepsia, peptic ulce
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1ac68e3ff2785eedaeb77ddc21b1368
https://doi.org/10.1016/s0011-393x(01)80089-8
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje